Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Open Access
- 30 August 2021
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 107 (2), 221-226
- https://doi.org/10.1136/bjophthalmol-2021-318880
Abstract
Background To explore the outcomes and mechanisms of intraocular pressure (IOP) control using low-dose transscleral cyclophotocoagulation (LDTSCP) followed by phacoemulsification in patients with prolonged acute primary angle closure (APAC). Methods Patients with prolonged APAC refractory to all other treatment modalities were prospectively recruited, and underwent LDTSCP (10 shots, 2 s duration, 120° treatment with the energy starting at 1500 mW and titrated to the level with audible burst but not exceeding 2000 mW) and anterior chamber paracentesis 1 week prior to phacoemulsification with intraocular lens implantation and viscogoniosynechiolysis. Postoperative IOP, vision, anatomic changes on anterior segment optical coherence tomography and complications were recorded. Results Twenty eyes with prolonged APAC were recruited. Median follow-up was 12 months (range 9–18), at which point the vision in all eyes had improved and IOP was ≤17 mm Hg on no antiglaucoma medications. Following LDTSCP at postoperative day (POD) 1, IOP decreased in all eyes to a median 15 mm Hg (range: 6–28 mm Hg). Post-LDTSCP supraciliary effusion (SCE) occurred in 90% of eyes on POD1 or POD7 and ciliary body defect (CBD) was detected in 30% of eyes and resolved in all cases by postoperative month 1. Lower post-LDTSCP IOP was associated with more number of bursts (r=−0.558, p=0.011) and higher grade of SCE (r=−0.877, pConclusions LDTSCP-induced SCE may explain the post-LDTSCP IOP reduction seen in eyes with prolonged APAC. LDTSCP instead of traditional more extensive treatment, was sufficient to provide a relatively safe and effective bridge therapy prior to phacoemulsification. Trial registration number Chinese Clinical Trials Registry (ChiCTR1900023567).Keywords
Funding Information
- Capital’s Funds for Health Improvement and Research (2020-4-2059)
This publication has 35 references indexed in Scilit:
- Malignant Glaucoma: A Review of the Modern LiteratureJournal of Ophthalmology, 2012
- Conventional and emerging treatments in the management of acute primary angle closureClinical Ophthalmology, 2012
- Cyclodiode laser in the treatment of acute angle closureEye, 2012
- Reproducibility of Scleral Spur Identification and Angle Measurements Using Fourier Domain Anterior Segment Optical Coherence TomographyJournal of Ophthalmology, 2012
- Outcomes following acute primary angle closure in an Asian populationClinical & Experimental Ophthalmology, 2009
- Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsificationActa Ophthalmologica, 2008
- Current approaches to the management of acute primary angle closureCurrent Opinion in Opthalmology, 2007
- Angle Widening and Alteration of Ciliary Process Configuration after Cataract Surgery for Primary Angle ClosureOphthalmology, 2006
- Uveal effusion in primary angle-closure glaucomaOphthalmology, 2005
- Primary acute angle closure glaucoma associated with suprachoroidal fluid in three Chinese patientsEye, 2001